A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Montreal Canada

摘要

BackgroundThis paper will determine whether expanding Insite (North America’s first and only supervised injection facility) to more locations in Canada such as Montreal, cost less than the health care consequences of not having such expanded programs for injection drug users.